O
Oncolytics Biotech Inc. (ONCY)
NCM – Real Time Price. Currency in USD
0.95
+0.03 (2.99%)
At close: Jun 26, 2026, 4:00 PM EDT
0.94
-0.01 (-1.07%)
After-hours: Jun 26, 2026, 7:53 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.95
+0.03 (2.99%)
At close: Jun 26, 2026, 4:00 PM EDT
0.94
-0.01 (-1.07%)
After-hours: Jun 26, 2026, 7:53 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $5.5M significantly exceed its total debt $508.0K, ensuring strong financial flexibility
Total current assets $7.5M exceed Total current liabilities $5.4M, highlighting excellent liquidity
Debt-to-equity ratio (-0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$7.3M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.38 | 6.05 | 7.0 | |
| Quick ratio | 1.38 | 5.63 | 7.0 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 0.06 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 5.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -301K | -299K | -87K | -70K | -113K |
| Operating Income | -21M | -25M | -26M | -29M | -26M |
| Net Income | -19M | -21M | -23M | -29M | -26M |
| EBITDA | -20M | -25M | -25M | -29M | -26M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -4.01 | 1.0 |
| Next quarter | N/A | 46.27 | 5.5 |
| Current year | N/A | -10.59 | 1.0 |
| Next year | N/A | 16.48 | 5.0 |
| Weighted average score | 3.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -513.33 | -986.8 | -16.51 | 3.3 |
| Y/Y | 999 | -96.19 | -42.36 | -54.17 | 3.3 |
| 3y average | 999 | -14.92 | 11.23 | -4.21 | 4.8 |
| 5y average | 999 | -12.14 | 12.74 | -4.37 | 5.0 |
| Weighted average score | 4.1 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |